A Cleveland Clinic-led team of scientists and physicians have discovered that the immune checkpoint protein VISTA can directly turn off tumor-fighting T-cells during immunotherapy and resist treatment.
Minnesota becomes first state to release report on 340B drug discount program for ‘safety-net’ hospitals
Minnesota hospitals participating in a controversial U.S. drug discount program reaped at least $630 million in revenue last year, and the largest institutions were the
November 25, 2024